drugset / Trial / NCT04814498
Drug-Drug Interaction (DDI) Study in Healthy Volunteers
NaSequentialOpen-labelTreatment
Summary
A Phase 1, Open Label, Fixed Sequence Study to Evaluate the Effect of BLD-0409 on the Single Dose Pharmacokinetics of a Cocktail of Probe Substrates for CYP450 Enzymes in Healthy Volunteers
Timeline
- Start
- 2021-05-03
- Primary completion
- 2021-09-17
- Completion
- 2022-01-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 20 mg | — |
| Subject | Caffeine | Small molecule | 50 mg | — |
| Subject | Cudetaxestat | Small molecule | — | — |
| Subject | Dextromethorphan | Unknown | 10 mg | — |
| Subject | Flurbiprofen | Small molecule | 10 mg | — |
| Subject | Midazolam | Small molecule | 1 mg | — |
| Subject | Omeprazole | Other / unclassified | 10 mg | — |
Indications
No indication recorded.